tradingkey.logo
tradingkey.logo
Suchen

Sol Gel Technologies Ltd

SLGL
Zur Watchlist hinzufügen
74.010USD
+2.020+2.81%
Handelsschluss 07/02, 13:00ETKurse um 15 Minuten verzögert
241.94MMarktkapitalisierung
VerlustKGV TTM

mehr Informationen über Sol Gel Technologies Ltd Unternehmen

Sol-Gel Technologies Ltd is a clinical-stage dermatology company. The Company is focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The Company’s offers a range of products twins, sirs-t, and vered. The Company is designed its proprietary, silica-based microencapsulation technology platform to enhance the tolerability and stability of topical drugs while maintaining their efficacy. Topical drugs often struggle to balance achieving both high efficacy and high tolerability. Its technology platform entraps active ingredients in an inert, inorganic silica shell, which creates an unnoticeable barrier between the active ingredient and the skin.

Sol Gel Technologies Ltd Informationen

BörsenkürzelSLGL
Name des UnternehmensSol Gel Technologies Ltd
IPO-datumFeb 01, 2018
CEO- -
Anzahl der mitarbeiter34
WertpapierartOrdinary Share
GeschäftsjahresendeFeb 01
AddresseGolda Meir 7
StadtNESS-ZIONA
BörseNASDAQ OMX - NASDAQ BASIC
LandIsrael
Postleitzahl- -
Telefon97289313433
Websitehttp://www.sol-gel.com
BörsenkürzelSLGL
IPO-datumFeb 01, 2018
CEO- -

Führungskräfte von Sol Gel Technologies Ltd

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Moshe (Mori) Arkin
Mr. Moshe (Mori) Arkin
Executive Chairman of the Board
Executive Chairman of the Board
143.26K
--
Mr. Ran Gottfried
Mr. Ran Gottfried
Lead Independent Director
Lead Independent Director
1.55K
--
Dr. Ofer Toledano, Ph.D.
Dr. Ofer Toledano, Ph.D.
Vice President - Research and Development
Vice President - Research and Development
--
--
Dr. Ofra Levy-Hacham, Ph.D.
Dr. Ofra Levy-Hacham, Ph.D.
Vice President - Clinical and Regulatory Affairs
Vice President - Clinical and Regulatory Affairs
--
--
Dr. Karine Neimann, Ph.D.
Dr. Karine Neimann, Ph.D.
Vice President - Projects and Planning, Chief Chemist
Vice President - Projects and Planning, Chief Chemist
--
--
Dr. Itzik Yosef, Ph.D.
Dr. Itzik Yosef, Ph.D.
Vice President - Operations
Vice President - Operations
--
--
Dr. Dubi (Dov) Zamir, Ph.D.
Dr. Dubi (Dov) Zamir, Ph.D.
Vice President - Special Projects
Vice President - Special Projects
--
--
Mr. Itai Arkin
Mr. Itai Arkin
Director
Director
--
--
Dr. Shmuel (Muli) Ben Zvi, Ph.D.
Dr. Shmuel (Muli) Ben Zvi, Ph.D.
Independent Director
Independent Director
--
--
Ms. Hani Lerman
Ms. Hani Lerman
Director
Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Moshe (Mori) Arkin
Mr. Moshe (Mori) Arkin
Executive Chairman of the Board
Executive Chairman of the Board
143.26K
--
Mr. Ran Gottfried
Mr. Ran Gottfried
Lead Independent Director
Lead Independent Director
1.55K
--
Dr. Ofer Toledano, Ph.D.
Dr. Ofer Toledano, Ph.D.
Vice President - Research and Development
Vice President - Research and Development
--
--
Dr. Ofra Levy-Hacham, Ph.D.
Dr. Ofra Levy-Hacham, Ph.D.
Vice President - Clinical and Regulatory Affairs
Vice President - Clinical and Regulatory Affairs
--
--
Dr. Karine Neimann, Ph.D.
Dr. Karine Neimann, Ph.D.
Vice President - Projects and Planning, Chief Chemist
Vice President - Projects and Planning, Chief Chemist
--
--
Dr. Itzik Yosef, Ph.D.
Dr. Itzik Yosef, Ph.D.
Vice President - Operations
Vice President - Operations
--
--

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Sol Gel Technologies Ltd?

Die fünf größten Anteilseigner von Sol Gel Technologies Ltd sind: Mr. Moshe (Mori) Arkin

Wie viele Institutionen halten Anteile an Sol Gel Technologies Ltd (SLGL)?

Mit Stand vom 2026Q1 halten 39 Institutionen Anteile an Sol Gel Technologies Ltd, mit einem Gesamtmarktwert von etwa 1.00M, was 30.93% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -175336.00 gestiegen.